Evidence map›Paper›PMID 41511856›Full record

ArticleJMIR diabetes2026

Artificial Intelligence in Diabetic Kidney Disease Research: Bibliometric Analysis From 2006 to 2024.

Xingyuan Li, Liming Xiao, Fenghao Yang, Fang Liu

Abstract read
In one paragraph

Article in JMIR diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xingyuan LiDepartment of Nephrology, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, 610041, China, 86 13880602361.ORCID http://orcid.org/0009-0009-5897-9614
Liming XiaoDepartment of Nephrology, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, 610041, China, 86 13880602361.ORCID http://orcid.org/0009-0009-7158-1686
Fenghao YangDepartment of Nephrology, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, 610041, China, 86 13880602361.ORCID http://orcid.org/0009-0006-1578-5316
Fang LiuDepartment of Nephrology, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, 610041, China, 86 13880602361.ORCID http://orcid.org/0000-0003-1121-3004

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetic kidney disease (DKD) is a major complication of diabetes and the leading cause of end-stage renal disease globally. Artificial intelligence (AI) technologies have shown increasing potential in DKD research for early detection, risk prediction, and disease management. However, the landscape of AI applications in this field remains incompletely mapped, especially in terms of collaboration networks, thematic evolution, and clinical translation. Objective: This study aims to perform a comprehensive bibliometric and translational analysis of AI-related DKD research published between 2006 and 2024, identifying publication trends, research hotspots, key contributors, collaboration patterns, and the extent of clinical validation and explainability. Methods: A systematic search of the Web of Science Core Collection was conducted to identify English-language original articles applying AI technologies to DKD. Articles were screened following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. Bibliometric visualization was performed using CiteSpace and VOSviewer to assess coauthorship, institutional and country collaboration, keyword evolution, and citation bursts. A qualitative review was conducted to evaluate clinical validation, model explainability, and real-world implementation. Results: Out of 1158 retrieved records, 384 studies met the inclusion criteria. Global publications on AI in DKD increased rapidly after 2019. China led in publication volume, followed by the United States, India, and Iran. Keyword analysis showed a thematic transition from early biomarker and proteomic research to deep learning, clinical prediction models, and management tools. Despite methodological advances, few studies included external validation or explainability frameworks. Notable translational efforts included DeepMind's acute kidney injury predictor and a chronic kidney disease prediction model developed by Sumit, yet widespread real-world integration remains limited. Conclusions: AI research in DKD has grown substantially over the past 2 decades, with expanding international collaboration and diversification of research themes. However, challenges persist in clinical applicability, model transparency, and global inclusivity. Future research should prioritize explainable AI, multicenter validation, and integration into clinical workflows to support effective translation of AI innovations into DKD care.

Indexed as

artificial intelligencebibliometric analysisclinical validationdiabetic kidney diseaseexplainable AIglobal collaboration

Identifiers

PMID41511856
PMCPMC12786635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.